Current Status of Liver Transplantation Using Marginal Grafts

2018 ◽  
Vol 33 (6) ◽  
pp. 553-564
Author(s):  
Amr Badawy ◽  
Toshimi Kaido ◽  
Shinji Uemoto
2020 ◽  
Vol 82 ◽  
pp. 9-13 ◽  
Author(s):  
Varvara A. Kirchner ◽  
Nicolas Goldaracena ◽  
Gonzalo Sapisochin ◽  
Roberto Hernandez Alejandro ◽  
Shimul A. Shah

1977 ◽  
Vol 70 (4) ◽  
pp. 389 ◽  
Author(s):  
Thomas E. Starzl ◽  
Charles W. Putnam ◽  
Lawrence J. Koep

Author(s):  
Quirino Lai ◽  
Rafael S. Pinheiro ◽  
Juan M. Rico Juri ◽  
Edward Castro Santa ◽  
Jan P. Lerut

2004 ◽  
Vol 10 (10) ◽  
pp. 1223-1232 ◽  
Author(s):  
Srikanth Reddy ◽  
Miguel Zilvetti ◽  
Jens Brockmann ◽  
Andrew McLaren ◽  
Peter Friend

2021 ◽  
pp. 106005
Author(s):  
Sami Akbulut ◽  
Cemalettin Koc ◽  
Tevfik Tolga Sahin ◽  
Sezai Yilmaz

2008 ◽  
Vol 108 (1) ◽  
pp. 45-51 ◽  
Author(s):  
D. Monbaliu ◽  
K. Vekemans ◽  
Q. Liu ◽  
V. Heedfeld ◽  
T. Wylin ◽  
...  

2018 ◽  
Vol 24 (12) ◽  
pp. 1757-1761 ◽  
Author(s):  
Carlos Benítez ◽  
Rodrigo Wolff

2021 ◽  
pp. flgastro-2020-101425
Author(s):  
N Thomas Burke ◽  
James B Maurice ◽  
David Nasralla ◽  
Jonathan Potts ◽  
Rachel Westbrook

Liver transplant is a life-saving treatment with 1-year and 5-year survival rates of 90% and 70%, respectively. However, organ demand continues to exceed supply, such that many patients will die waiting for an available organ. This article reviews for the general gastroenterologist the latest developments in the field to reduce waiting list mortality and maximise utilisation of available organs. The main areas covered include legislative changes in organ donation and the new ‘opt-out’ systems being rolled out in the UK, normothermic machine perfusion to optimise marginal grafts, a new national allocation system to maximise benefit from each organ and developments in patient ‘prehabilitation’ before listing. Current areas of research interest, such as immunosuppression withdrawal, are also summarised.


2020 ◽  
Author(s):  
Xin Duan ◽  
Liting Yan ◽  
Chao Qian ◽  
Wei Zhang ◽  
Yan Shen ◽  
...  

Abstract Background: The growing disparity between organ availability and the number of candidates for organ transplantation has urged the use of marginal grafts including grafts from syphilis-positive donors. However, few knowledges could be acknowledged about this due to the rare data from case reports. Therefor we evaluate our data and summarize our experience of the management of liver grafts from syphilis-positive donors.Methods: From January 2015 to December 2019, 22 adult patients received liver transplantation from syphilis-positive donors while 873 patients got liver transplantation from syphilis-negative donors at our center. Given the imbalance in several baseline variables, propensity score matching was used. The outcomes were compared including complications, hospital stay, recovery of liver function and survival of the two groups and the management of the recipients was reviewed.Results: There were no differences in complications and hospital stay of the recipients after transplantation. And it showed similar trends in the liver function recovery. Patient and graft survivals were comparable to that of syphilis-negative grafts. And benzathine penicillin is effective to protect the recipients from syphilis.Conclusions: The use of liver grafts from syphilis-positive donors does not to increase the morbidity and mortality of the recipients. Also, the prophylactic theory of benzathine penicillin is helpful.


Sign in / Sign up

Export Citation Format

Share Document